Literature DB >> 3970589

The genetic basis of porphyria cutanea tarda.

R Enriquez de Salamanca, A Olmos, M L Peña, L Berges, J Perpiñá.   

Abstract

In order to confirm the genetic character of porphyria cutanea tarda (PCT), the quantitative and qualitative porphyrin excretion from 56 unrelated PCT patients and 259 relatives was analyzed by a sensitive fluorimetric thin-layer chromatographic technique. Porphyrin excretion abnormalities were observed in 111 (35.24%) of the 315 subjects studied. Of the 259 relatives, 55 (21.24%) suffered from manifest (24 cases) or subclinical (31 cases) PCT. The relatives from the older generation or a generation similar to the propositi were more frequently affected than those from a younger generation. A clear family incidence was observed in 32 families, while PCT was apparently limited to the propositi in the remaining 24. It is discussed whether these latter families correspond to the so-called "sporadic" type of PCT or include porphyric gene carriers lacking biochemical expression of the disease. While the measurements of the activity of the defective enzyme (uroporphyrinogen decarboxylase) for the genetic research of PCT turned out to be impracticable in hepatic tissue and contradictory in erythrocytes, our study confirms that the familial character of this disease may be revealed by the chromatographic analysis of the porphyrin excretion pattern.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970589     DOI: 10.1007/bf00406473

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  24 in total

Review 1.  [Current concepts on the pathogenesis of delayed cutaneous porphyria].

Authors:  R Enríquez de Salamanca; F Arnalich
Journal:  Rev Clin Esp       Date:  1979-03-31       Impact factor: 1.556

Review 2.  Porphyrin metabolism in porphyria cutanea tarda.

Authors:  G H Elder
Journal:  Semin Hematol       Date:  1977-04       Impact factor: 3.851

3.  Quantitative and qualitative porphyrin excretion in normal subjects.

Authors:  R E de Salamanca; M L Peña; S Chinarro; A Olmos; D Mingo; C Molina; J J Muñoz
Journal:  Int J Biochem       Date:  1982

4.  Acquired and inherited porphyria: clinical and biochemical features.

Authors:  P H Magnin; A M del C Batlle; E A de Xifra; M Lenczner; V E Parera; A M Stella
Journal:  Int J Dermatol       Date:  1982-04       Impact factor: 2.736

5.  Familial and sporadic porphyria cutanea: two different diseases.

Authors:  H de Verneuil; G Aitken; Y Nordmann
Journal:  Hum Genet       Date:  1978-10-31       Impact factor: 4.132

6.  Genome and chromosome mutations in porphyria cutanea tarda.

Authors:  L Lukanov; M Tsoneva; M Krachunova; E Ivanov; D Adjarov
Journal:  Br J Dermatol       Date:  1981-08       Impact factor: 9.302

7.  Porphyria cutanea tarda in three generations of a single family.

Authors:  A V Benedetto; J P Kushner; J S Taylor
Journal:  N Engl J Med       Date:  1978-02-16       Impact factor: 91.245

8.  Decreased hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda.

Authors:  B F Felsher; N M Carpio; D W Engleking; A T Nunn
Journal:  N Engl J Med       Date:  1982-04-01       Impact factor: 91.245

9.  Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.

Authors:  G H Elder; D M Sheppard; J A Tovey; A J Urquhart
Journal:  Lancet       Date:  1983-06-11       Impact factor: 79.321

10.  Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase.

Authors:  G H Elder; D M Sheppard; R E De Salamanca; A Olmos
Journal:  Clin Sci (Lond)       Date:  1980-06       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.